Hepatic portal cholangiocarcinoma: a clinical analysis of 70 cases
Hong-Yi Zhang, Ya-Lin Kong, Hong-Yi Zhang, Xiao-Jun He, Hui Zhang, Cheng-Li Liu, Gang Zhao, Mei Xiao and Xi-Dong Zhang and Zhi-Qiang Feng
World Journal of Surgical Research 2012, 1:1
Introduction: Hepatic portal cholangiocarcinoma is associated with poor survival, and this article analyzes an effective therapeutic method.
Patients and Methods: A retrospective analysis was performed in 70 cases of hepatic portal cholangiocarcinoma admitted between January 2004 and February 2007 in Air Force General Hospital, Beijing, China.
Results: Forty-seven cases we performed hepaticodocho-jejunostomy after resection of hepatic portal cholangiocarcinoma. Internal or external biliary drainage and channels for internal radiation were performed for those who were unfit for resection. Of the 70 cases, 5 died within 15 months, 27 survived more than 24 months, and the other cases had survived for 4-18 months.
Conclusions: Surgery is the primary therapeutic method for hepatic portal cholangiocarcinoma. Internal or external biliary drainage can prolong the life span.